Hidradenitis Suppurativa (HS) Completed Phase 2 Trials for Apremilast (DB05676)

Also known as: Hidradenitis Suppurativa / Hidradenitis / Sweat gland inflammation / Acne inversa

IndicationStatusPhase
DBCOND0054533 (Hidradenitis Suppurativa (HS))Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02695212Single Center Study of Apremilast for the Treatment of Hidradenitis SuppurativaOther
NCT03049267Short-term Safety, Efficacy and Mode of Action of Apremilast in Moderate Suppurative HidradenitisTreatment